Zobrazeno 1 - 10
of 35
pro vyhledávání: '"A M Pilaro"'
Publikováno v:
Clinical Trials of Genetic Therapy with Antisense DNA and DNA Vectors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::743140900bc72eb87b804c1cdfc2b0c5
https://doi.org/10.1201/9781003064657-12
https://doi.org/10.1201/9781003064657-12
Autor:
Richard T. Lostritto, Martha Donoghue, Hong Zhao, Anshu Marathe, Anne M. Pilaro, Steven Lemery, Kun He, Stacy S. Shord, William M. Adams, Joseph E. Gootenberg, Lori Kotch, Liang Zhou, Rajeshwari Sridhara, Richard Pazdur, Weishi Yuan, Patricia Keegan, Vaishali Jarral, Ying Wang, Josephine M. Jee
Publikováno v:
Clinical Cancer Research. 18:1496-1505
This work describes the considerations that led to the approval by the U.S. Food and Drug Administration (FDA), on November 15, 2010, of eribulin mesylate (Halaven; Eisai, Inc.) for the treatment of patients with refractory metastatic breast cancer.
Autor:
Tao Wang, William David McGuinn, David Jacobson-Kram, Abigail Jacobs, John C. Lipscomb, Daniel Lapadula, Paul Brown, Anne M. Pilaro
Publikováno v:
Toxicological Sciences. 118:356-367
Since the inception of the International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) in 1990, six-party Expert Working Groups (EWG) have developed and revised numerous guidelines o
Autor:
Pengfei Song, Robert Justice, Shenghui Tang, Barbara L. Rellahan, Amy Tilley, Anne M. Pilaro, Amna Ibrahim, Wendy C. Weinberg, Somesh Chattopadhyay, Patricia Hughes, Nancy S. Scher, Qi Liu, Kimberly Ringgold, Gideon M. Blumenthal, Kathryn E. King, Bo Chi, Colleen Thomas, Laurie Graham, Richard Pazdur, Patricia Cortazar
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 19(18)
On June 8, 2012, the U.S. Food and Drug Administration (FDA) approved pertuzumab (Perjeta, Genentech) for use in combination with trastuzumab (Herceptin, Genentech) and docetaxel for the treatment of patients with HER2-positive metastatic breast canc
Publikováno v:
Biotherapy. 9:199-208
Recombinant human interleukin 1 alpha (rh IL-1 alpha) and etoposide (VP-16) synergize for direct growth inhibition of several human tumor cell lines in vitro. Our previous studies demonstrated that VP-16 increased the number of membrane-associated IL
Autor:
Jerrold M. Ward, Robert H. Wiltrout, Akiko Kojima, Kunio Nagashima, Thomas J. Sayers, Kenji Kaneda, Theresa A. Wiltrout, Craig W. Reynolds, John R. Ortaldo, Matthew A. Gonda, Anne M. Pilaro
Publikováno v:
Biomedical Research. 17:53-65
Publikováno v:
Molecular Therapy. 8:8-10
and discussed their relevance to biologic products. Elesperu stated that genotoxicity assays are designed as surrogate assays to detect rare occurrences of genetic damage, and noted that although no single test alone will detect all types of mutageni
Publikováno v:
The Journal of Immunology. 153:333-342
Isolated murine splenic NK cells and the cultured murine endothelioma cell line, eEND2, were used to study the effects of cytokines on NK cell/endothelial cell adhesion. Treatment of eEND2 cells with TNF-alpha induced a marked increase (four- to seve
Autor:
Matthew A. Gonda, Robert H. Wiltrout, Anne M. Pilaro, Thoma J. Sayers, John R. Ortaldo, Kenji Kaneda, Kunio Nagashima
Publikováno v:
Cell and Tissue Research. 276:187-195
Large granular lymphocytes (LGL) comprise a natural defense system in the liver and exert an inhibitory effect on tumor cell metastasis. In order to demonstrate the maturation of LGL in the liver from the morphological aspect, we evaluated electron-m